PTC Therapeutics Inc (STU:BH3)
€ 36.8 0 (0%) Market Cap: 2.89 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

Q2 2019 PTC Therapeutics Inc Earnings Call Transcript

Aug 06, 2019 / 08:30PM GMT
Release Date Price: €38.21 (+1.30%)
Operator

Good day, ladies and gentlemen, and thank you for your patience. You've joined the PTC Therapeutics second quarter corporate update and financial results conference call. (Operator Instructions) As a reminder, this conference maybe recorded. I would now like to turn the call over to your host, Chief of Staff to the CEO, Timothy Dyer. Sir, you may begin.

Timothy Dyer
PTC Therapeutics, Inc. - Chief of Staff to the CEO

Hello. Good afternoon and thank you for joining us to discuss our 2019 second quarter corporate updates and financial results. Joining me on today's call is our CEO, Stuart Peltz; our Chief Operating Officer, Marcio Souza; and our Chief Financial Officer, Emily Hill.

Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Please take a moment to review our slide on our simultaneous presentation, which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements as any and such risk can materially and adversely

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot